Skip to Main Content

Advertisement

Skip Nav Destination

Issues

TOP READS

J Immunol (2022) 208 (1): 1–2.

ANTIGEN RECOGNITION AND RESPONSES

J Immunol (2022) 208 (1): 3–15.

  • Protective HLA alleles in HIV infection recruit biased T cell repertoires.

  • The T cell repertoire is highly similar between different rates of HIV progression.

AUTOIMMUNITY

J Immunol (2022) 208 (1): 16–26.

  • HLA-DR can be engineered to function as a CAR molecule in CD8+ T cells.

  • CD8+ T cells expressing HLA-DR1 CAR molecules efficiently lyse CD4+ T cells in vivo.

  • HLA-DR1:CII peptide CAR T cells inhibit the development of autoimmune arthritis.

CLINICAL AND HUMAN IMMUNOLOGY

J Immunol (2022) 208 (1): 27–37.

  • Phenotypic differences exist between cord and birth peripheral blood CD4 cells.

  • Synchronous increase of Th17/Treg cells is disrupted by HIV/ART exposure.

  • Intrauterine HIV exposure was associated with a biomarker for epithelial gut damage.

J Immunol (2022) 208 (1): 38–48.

  • HuR ablation in CD4+ T cells alleviates allergic airway inflammation in the OVA model.

  • CMLD-2 inhibits Th2 cytokine levels in CD4+ T cells from type 2 high asthmatics.

  • AICAR inhibits cytokine production in CD4+ cells in non–type 2 and type 2 high asthmatics.

IMMUNE REGULATION

J Immunol (2022) 208 (1): 49–53.

  • HLA-H*02:07 encodes a membrane-bound protein.

  • HLA-H*02:07 inhibits human effector cell activity.

  • HLA-H*02:07 is of archaic origin.

IMMUNOTHERAPY AND VACCINES

J Immunol (2022) 208 (1): 54–62.

  • IL-2 and CD107a expression in HIV-specific T cells is enhanced with IC blockade.

  • Combinations of two Abs to LAG-3, CTLA-4, or TIGIT showed the greatest activity.

  • CD8 count and CD4/CD8 ratio correlate with magnitude of response to IC blockade.

INFECTIOUS DISEASE AND HOST RESPONSE

J Immunol (2022) 208 (1): 63–73.

  • OPTN mediates protection from HSV-2 by regulating the intrinsic immune response.

  • OPTN loss results in hyperproliferation of HSV-2 and reduced CCL5 induction.

  • OPTN/CCL5 nexus restricts hyperproliferative spread of primary HSV-2 infection.

J Immunol (2022) 208 (1): 74–84.

  • ORAI1 regulates tonic IFN-I signaling via modulating baseline Ca2+ levels.

  • Deletion of ORAI1 enhances host susceptibility to SARS-CoV-2 infection.

INNATE IMMUNITY AND INFLAMMATION

J Immunol (2022) 208 (1): 85–96.

  • Shed PrPC derivatives and PrPC in extracellular vesicles regulate innate immunity.

  • The macrophage NMDA-R/LRP1 complex mediates the activity of PrPC released by cells.

  • The NMDA-R/LRP1 complex functions as an extracellular vesicle receptor in target cells.

J Immunol (2022) 208 (1): 97–109.

  • PWD and 11.2 DCs have less NO production than B6 DCs.

  • PWD and 11.2 DCs maintain postactivation mitochondrial respiration.

  • NO levels between B6 and 11.2 DCs inversely correlate with L. monocytogenes control.

J Immunol (2022) 208 (1): 110–120.

  • Following MWCNT exposure, eosinophilic inflammation is more severe in female airways.

  • ILC2s are not required for MWCNT-induced eosinophilia.

  • Female AMs develop a more exaggerated M2a phenotype than those of males after MWCNT exposure.

J Immunol (2022) 208 (1): 121–132.

  • Obese Srgn−/− mice have reduced adipose tissue inflammation and adipocyte size.

  • Adipose tissue Srgn mRNA is predominantly expressed by resident immune cells.

  • Patients with obesity have increased SRGN mRNA expression in adipose tissue.

J Immunol (2022) 208 (1): 133–142.

  • Recombinant and plasma-derived human C5a signal comparatively at C5aR1 and C5aR2.

  • Recombinant but not plasma-derived human C5a induces IL-6 release in macrophages.

  • The recombinant C5a-induced cytokine response is independent of C5aR1 or endotoxin.

MOLECULAR AND STRUCTURAL IMMUNOLOGY

J Immunol (2022) 208 (1): 143–154.

  • Ig enhancers (DIVACs) increase RNA Pol II stalling in the SHM target gene.

  • DIVACs do not operate by increasing antisense transcription.

J Immunol (2022) 208 (1): 155–168.

  • IL-2 and IL-7 induce S6Kstrong and S6Kweak signals, leading to forming TE and TM cells.

  • IL-7–stimulated S6Kweak signaling controls T cell memory via FOXO1 and AMPK pathways.

TUMOR IMMUNOLOGY

J Immunol (2022) 208 (1): 169–180.

  • Active TGF-β is present in many cancer indications.

  • dnTGFβRII can be coexpressed in T cells with engineered TCRs.

  • dnTGFβRII–expressing T cells are resistant to inhibition by TGF-β.

NOVEL IMMUNOLOGICAL METHODS

J Immunol (2022) 208 (1): 181–189.

  • The IgNAR region >3.13 Mb was enriched 245.531-fold by CATCH.

  • Twenty holes of 3508 bp of the IgNAR region were filled using PacBio HiFi reads.

  • Five potential germline V alleles of IgNAR1 were found.

Close Modal

or Create an Account

Close Modal
Close Modal